Dr. Aftab S Ahmad Investigator

NPI1578625505

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$12,937.06
from 78 payments in the last 6 years

Total Cash or Cash Equivalent

$4,517.43
from 15 payments in the last 6 years

Total In-kind Items & Services

$8,419.63
from 63 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
12/01/2021 General (Non-Research) In-kind items and services Food and Beverage $26.76 Details
Payment from Biohaven Pharmaceuticals, Inc.
Payment Record ID 852396229
07/29/2021 General (Non-Research) In-kind items and services Food and Beverage $8.15 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 834350111
10/21/2021 General (Non-Research) In-kind items and services Food and Beverage $14.77 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 834341069
09/29/2021 General (Non-Research) In-kind items and services Food and Beverage $119.05 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 834324445
03/22/2021 General (Non-Research) In-kind items and services Food and Beverage $11.49 Details
Payment from Lilly USA, LLC
Payment Record ID 818919865
09/29/2021 General (Non-Research) In-kind items and services Food and Beverage $17.43 Details
Payment from Novo Nordisk Inc
Payment Record ID 811014051
07/22/2021 General (Non-Research) In-kind items and services Food and Beverage $23.10 Details
Payment from Novo Nordisk Inc
Payment Record ID 810822575
09/08/2021 General (Non-Research) In-kind items and services Food and Beverage $14.45 Details
Payment from Boehringer Ingelheim Pharmaceuticals, Inc.
Payment Record ID 763569034
10/21/2020 General (Non-Research) In-kind items and services Food and Beverage $10.97 Details
Payment from Abbott Laboratories
Payment Record ID 749023067
04/02/2020 General (Non-Research) In-kind items and services Food and Beverage $17.58 Details
Payment from Gilead Sciences, Inc.
Payment Record ID 747949889
06/18/2020 General (Non-Research) In-kind items and services Food and Beverage $13.04 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 747702175
11/21/2020 General (Non-Research) In-kind items and services Food and Beverage $14.12 Details
Payment from Novo Nordisk Inc
Payment Record ID 744998421
09/10/2020 General (Non-Research) In-kind items and services Food and Beverage $15.81 Details
Payment from Novo Nordisk Inc
Payment Record ID 744872001
01/30/2020 General (Non-Research) In-kind items and services Food and Beverage $16.96 Details
Payment from Amarin Pharma Inc.
Payment Record ID 739759607
06/10/2020 General (Non-Research) In-kind items and services Food and Beverage $14.28 Details
Payment from Salix Pharmaceuticals, a division of Bausch Health US, LLC
Payment Record ID 737479773
06/15/2020 General (Non-Research) In-kind items and services Food and Beverage $22.62 Details
Payment from Lilly USA, LLC
Payment Record ID 728311319
10/28/2020 General (Non-Research) In-kind items and services Food and Beverage $19.08 Details
Payment from Boston Scientific Corporation
Payment Record ID 725554643
09/10/2019 Research In-kind items and services $30.86 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A PHASE 3 STUDY TO COMPARE THE EFFICACY AND SAFETY OF GEPOTIDACIN WITH
Payment Record ID 709082751
09/10/2019 Research In-kind items and services $213.14 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A PHASE 3 STUDY TO COMPARE THE EFFICACY AND SAFETY OF GEPOTIDACIN WITH
Payment Record ID 709081463
08/27/2019 General (Non-Research) In-kind items and services Food and Beverage $11.52 Details
Payment from SANOFI-AVENTIS U.S. LLC
Payment Record ID 694139315
07/18/2019 General (Non-Research) In-kind items and services Food and Beverage $11.73 Details
Payment from SANOFI-AVENTIS U.S. LLC
Payment Record ID 694111177
10/24/2019 General (Non-Research) In-kind items and services Food and Beverage $19.23 Details
Payment from OptiNose US, Inc.
Payment Record ID 684269861
06/26/2019 General (Non-Research) In-kind items and services Food and Beverage $19.08 Details
Payment from OptiNose US, Inc.
Payment Record ID 684269803
07/16/2019 General (Non-Research) In-kind items and services Food and Beverage $14.30 Details
Payment from Lilly USA, LLC
Payment Record ID 657649051
04/05/2019 Research In-kind items and services Drug $36.06 Details
Payment from AbbVie, Inc.
Paymment Research Study M16-100
Payment Record ID 647627735
04/05/2019 Research In-kind items and services Drug $58.57 Details
Payment from AbbVie, Inc.
Paymment Research Study M16-100
Payment Record ID 647627733
04/05/2019 Research In-kind items and services Drug $487.02 Details
Payment from AbbVie, Inc.
Paymment Research Study M16-100
Payment Record ID 647627731
04/05/2019 Research In-kind items and services Drug $18.86 Details
Payment from AbbVie, Inc.
Paymment Research Study M16-100
Payment Record ID 647627729
04/05/2019 Research In-kind items and services Drug $18.75 Details
Payment from AbbVie, Inc.
Paymment Research Study M16-100
Payment Record ID 647627727
04/04/2019 Research In-kind items and services Drug $204.06 Details
Payment from AbbVie, Inc.
Paymment Research Study M16-100
Payment Record ID 647627725
05/03/2019 Research In-kind items and services Drug $38.69 Details
Payment from AbbVie, Inc.
Paymment Research Study M16-100
Payment Record ID 647627723
09/29/2018 General (Non-Research) In-kind items and services Travel and Lodging $55.95 Details
Payment from Allergan Inc.
Payment Record ID 596145929
09/29/2018 General (Non-Research) In-kind items and services Travel and Lodging $56.46 Details
Payment from Allergan Inc.
Payment Record ID 596145924
09/29/2018 General (Non-Research) In-kind items and services Travel and Lodging $27.22 Details
Payment from Allergan Inc.
Payment Record ID 596145913
09/29/2018 General (Non-Research) In-kind items and services Travel and Lodging $370.41 Details
Payment from Allergan Inc.
Payment Record ID 596145903
09/29/2018 General (Non-Research) In-kind items and services Travel and Lodging $190.87 Details
Payment from Allergan Inc.
Payment Record ID 596145893
09/27/2018 General (Non-Research) In-kind items and services Food and Beverage $43.79 Details
Payment from Allergan Inc.
Payment Record ID 596145883
09/27/2018 General (Non-Research) In-kind items and services Food and Beverage $19.21 Details
Payment from Allergan Inc.
Payment Record ID 596145877
09/27/2018 General (Non-Research) In-kind items and services Food and Beverage $50.00 Details
Payment from Allergan Inc.
Payment Record ID 596145868
09/27/2018 General (Non-Research) In-kind items and services Food and Beverage $144.36 Details
Payment from Allergan Inc.
Payment Record ID 596145859
09/27/2018 General (Non-Research) In-kind items and services Food and Beverage $18.34 Details
Payment from Allergan Inc.
Payment Record ID 596145851
09/27/2018 General (Non-Research) In-kind items and services Food and Beverage $74.62 Details
Payment from Allergan Inc.
Payment Record ID 596145843
07/26/2018 General (Non-Research) In-kind items and services Food and Beverage $10.52 Details
Payment from Lilly USA, LLC
Payment Record ID 559163273
12/10/2018 General (Non-Research) In-kind items and services Food and Beverage $11.17 Details
Payment from Lilly USA, LLC
Payment Record ID 559163271
01/20/2017 General (Non-Research) In-kind items and services Travel and Lodging $577.75 Details
Payment from Novo Nordisk AS
Payment Record ID 468291951
01/20/2017 General (Non-Research) In-kind items and services Food and Beverage $403.75 Details
Payment from Novo Nordisk AS
Payment Record ID 468291949
01/20/2017 General (Non-Research) In-kind items and services Travel and Lodging $202.09 Details
Payment from Novo Nordisk AS
Payment Record ID 468291947
01/20/2017 General (Non-Research) In-kind items and services Travel and Lodging $121.18 Details
Payment from Novo Nordisk AS
Payment Record ID 468290473
04/25/2017 Research Cash or cash equivalent $125.00 Details
Payment from Allergan Inc.
Paymment Research Study A MULTICENTER, RANDOMIZED, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLOERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRANE WITH R WITHOUT AURA
Payment Record ID 463956687
04/25/2017 Research Cash or cash equivalent $175.00 Details
Payment from Allergan Inc.
Paymment Research Study A MULTICENTER, RANDOMIZED, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLOERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRANE WITH R WITHOUT AURA
Payment Record ID 463956683
03/16/2017 Research Cash or cash equivalent $125.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE
Payment Record ID 463956679
03/16/2017 Research Cash or cash equivalent $175.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE
Payment Record ID 463956677
02/02/2017 Research Cash or cash equivalent $700.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE
Payment Record ID 463956672
02/02/2017 Research Cash or cash equivalent $500.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE
Payment Record ID 463956667
02/02/2017 Research Cash or cash equivalent $175.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE
Payment Record ID 463956661
02/02/2017 Research Cash or cash equivalent $125.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE
Payment Record ID 463956657
01/31/2017 Research Cash or cash equivalent $356.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE
Payment Record ID 463956653
01/24/2017 Research Cash or cash equivalent $356.00 Details
Payment from Allergan Inc.
Paymment Research Study A MULTICENTER, RANDOMIZED, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLOERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRANE WITH R WITHOUT AURA
Payment Record ID 463956649
01/10/2017 Research Cash or cash equivalent $620.00 Details
Payment from Allergan Inc.
Paymment Research Study A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRAINE
Payment Record ID 463956645
01/05/2017 Research Cash or cash equivalent $175.00 Details
Payment from Allergan Inc.
Paymment Research Study A MULTICENTER, RANDOMIZED, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLOERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRANE WITH R WITHOUT AURA
Payment Record ID 463956641
01/05/2017 Research Cash or cash equivalent $125.00 Details
Payment from Allergan Inc.
Paymment Research Study A MULTICENTER, RANDOMIZED, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLOERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRANE WITH R WITHOUT AURA
Payment Record ID 463956637
01/05/2017 Research Cash or cash equivalent $620.00 Details
Payment from Allergan Inc.
Paymment Research Study A MULTICENTER, RANDOMIZED, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLOERABILITY OF ORAL UBROGEPANT IN THE ACUTE TREATMENT OF MIGRANE WITH R WITHOUT AURA
Payment Record ID 463956631
10/06/2017 General (Non-Research) In-kind items and services Food and Beverage $12.65 Details
Payment from Lilly USA, LLC
Payment Record ID 457116781
08/25/2017 General (Non-Research) In-kind items and services Food and Beverage $23.77 Details
Payment from Abbott Laboratories
Payment Record ID 452875427
09/14/2017 General (Non-Research) In-kind items and services Food and Beverage $24.99 Details
Payment from Abbott Laboratories
Payment Record ID 452869137
10/12/2017 General (Non-Research) In-kind items and services Food and Beverage $10.87 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 445108499
09/10/2016 General (Non-Research) In-kind items and services Travel and Lodging $572.50 Details
Payment from Novo Nordisk AS
Payment Record ID 392189792
09/08/2016 General (Non-Research) In-kind items and services Travel and Lodging $181.75 Details
Payment from Novo Nordisk AS
Payment Record ID 391914148
09/08/2016 General (Non-Research) In-kind items and services Food and Beverage $373.34 Details
Payment from Novo Nordisk AS
Payment Record ID 391914138
09/08/2016 General (Non-Research) In-kind items and services Travel and Lodging $1038.44 Details
Payment from Novo Nordisk AS
Payment Record ID 391914128
11/21/2016 General (Non-Research) Cash or cash equivalent Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $165.43 Details
Payment from Otonomy, Inc.
Payment Record ID 386948722
10/14/2016 General (Non-Research) In-kind items and services Travel and Lodging $41.77 Details
Payment from AstraZeneca AB
Payment Record ID 363478762
10/14/2016 General (Non-Research) In-kind items and services Food and Beverage $55.34 Details
Payment from AstraZeneca AB
Payment Record ID 363231844
10/14/2016 General (Non-Research) In-kind items and services Food and Beverage $23.88 Details
Payment from AstraZeneca AB
Payment Record ID 363172778
10/13/2016 General (Non-Research) In-kind items and services Travel and Lodging $94.79 Details
Payment from AstraZeneca AB
Payment Record ID 363066616
10/13/2016 General (Non-Research) In-kind items and services Travel and Lodging $287.60 Details
Payment from AstraZeneca AB
Payment Record ID 362920508
10/14/2016 General (Non-Research) In-kind items and services Food and Beverage $68.52 Details
Payment from AstraZeneca AB
Payment Record ID 362890376
10/13/2016 General (Non-Research) In-kind items and services Travel and Lodging $1670.20 Details
Payment from AstraZeneca AB
Payment Record ID 362403074